InvestSMART

Firebrick Pharma Limited (ASX:FRE)

ALERT: Price-sensitive ASX Announcement for FRE
Current share price for FRE : $0.028 -0.026 (-48.15%)+
Announcement
Release
31 Mar 2026 9:12AM
Price at Release
$0.054
Full Release
download
Summary
Firebrick Pharma Limited, trading on the ASX as FRE, announced it has secured firm commitments for a $1.5 million placement. The company issued approximately 31.9 million shares at $0.047 each, representing a discount to the market price. Investors receive an option for every two shares with an exercise price of $0.095, expiring in 2028. Proceeds will fund business development, new product development, and working capital needs. SP Corporate Advisory acted as lead manager for the placement.
Key Points
  • Firebrick Pharma Limited secured $1.5 million via a Placement.
  • Approximately 31,914,893 fully paid ordinary shares were issued at $0.047 per share.
  • The issue price was at a discount to previous trading values.
  • Options attached to the shares have an exercise price of $0.095 and expire on 4 July 2028.
  • Funds from the Placement will support business development, new product development, and working capital.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.